Commercialization in the Healthcare, Social Welfare and Agriculture Sectors
First written in FY2017-Q1. 7 of 15 entries say "Restated". Latest entry: FY2026.
0 other companies' latest entry also says "Other".
- FY2026Giving concrete form to the development of autonomous conveyance robots for medical and logistics applicationsAnnual report
「In the hospital conveyance field, we are promoting the development of autonomous mobile robots (AMRs) specialized for hospitals, with the aim of upgrading and reducing labor requirements in internal logistics at medical institutions.」
Regarding the existing policy of developing new products for the medical and logistics fields, the company is advancing development of hospital AMRs and has given concrete form to reducing implementation costs through a proprietary boarding method that does not require elevator integration equipment. - FY2025AdvancedAnnual report
「In the social infrastructure systems field, we have developed and begun operating monitoring and control systems that contribute to labor savings and preventive maintenance in inspections of electrical equipment for road management and water and wastewater facilities. In response to the increasing number of disasters, we will commercialize LP gas power generators that support business continuity planning and are environmentally friendly, contributing to disaster preparedness and mitigation.」
The company cited the development and start of operation of monitoring and control systems and the commercialization of LP gas power generators as concrete results in new fields. - FY2024ReframedAnnual report
「We will promote new product development in logistics and healthcare, while positioning semiconductor-related fields as growth drivers and expanding into automation and decarbonization/electrification.」
The focus areas have been reorganized from pursuing commercialization in regenerative medicine, agriculture and other fields to creating growth areas combining semiconductors, automation, decarbonization and electrification, and new product development in logistics and healthcare. - FY2021AdvancedAnnual report
「We will also work to create next-generation businesses, aiming to commercialize regenerative medicine applications at an early stage.」
Regarding regenerative medicine, the wording has progressed from a policy of development investment and joint research to explicitly targeting early commercialization. - FY2020-Q3RestatedAnnual report
「We will make active development investments, focusing on regenerative medicine and automotive-related businesses.」
The policy of investing in development centered on regenerative medicine and automotive-related businesses continues. - FY2020-Q1RestatedAnnual report
「We will make active development investments, focusing on regenerative medicine and automotive-related businesses.」
The policy of investing in development centered on regenerative medicine and automotive-related businesses continues. - FY2019AdvancedAnnual report
「To create next-generation businesses, we have begun jointly developing equipment with 神戸医療産業都市推進機構 in the regenerative medicine field to automate the mass cultivation and quality control of iPS cells and stem cells. In the agricultural field, we have advanced industry-academia joint research utilizing the research and development capabilities of Toyohashi University of Technology.」
The company reported concrete progress, including the start of joint development in regenerative medicine and the advancement of industry-academia joint research with a university in agriculture. - FY2019-Q2RestatedAnnual report
「We will make active development investments, focusing on regenerative medicine and automotive-related businesses.」
The new plan continues the policy of investing in development centered on regenerative medicine and automotive-related businesses, with the focus changed from the medical, welfare, agriculture and fisheries sectors. - FY2019-Q1ReframedAnnual report
「We will make active development investments, focusing on regenerative medicine and automotive-related businesses.」
The wording of the focus changed in the new plan from pursuing commercialization in the medical, welfare, agriculture and fisheries sectors to making development investments centered on regenerative medicine and automotive-related businesses. - FY2018-Q3RestatedAnnual report
「Using our Motion & Energy Control and measurement and control technologies, we will pursue commercialization in the medical and welfare sectors, where growth in the regenerative medicine-related industry and demand for labor-saving solutions in welfare are expected, and in the agriculture and fisheries sectors, where expectations are rising for food safety and a stable food supply.」
The company continues to pursue commercialization in the medical, welfare, agriculture and fisheries sectors by utilizing existing technologies. - FY2018-Q2RestatedAnnual report
「Using our Motion & Energy Control and measurement and control technologies, we will pursue commercialization in the medical and welfare sectors, where growth in the regenerative medicine-related industry and demand for labor-saving solutions in welfare are expected, and in the agriculture and fisheries sectors, where expectations are rising for food safety and a stable food supply.」
The company continues to pursue commercialization in the medical, welfare, agriculture and fisheries sectors by utilizing existing technologies. - FY2018-Q1RaisedAnnual report
「Using our Motion & Energy Control and measurement and control technologies, we will pursue commercialization in the medical and welfare sectors, where growth in the regenerative medicine-related industry and demand for labor-saving solutions in welfare are expected, and in the agriculture and fisheries sectors, where expectations are rising for food safety and a stable food supply.」
The scope has expanded from the agricultural sector to the agriculture and fisheries sectors. - FY2017-Q3RestatedAnnual report
「Using our Motion & Energy Control and measurement and control technologies, we will pursue commercialization in the medical and welfare sectors, where growth in the regenerative medicine-related industry and demand for labor-saving solutions in welfare are expected, and in the agricultural sector, where expectations are rising for food safety and a stable food supply.」
The company continues to pursue commercialization in the medical, welfare and agricultural sectors by utilizing existing technologies. - FY2017-Q2RestatedAnnual report
「Using our Motion & Energy Control and measurement and control technologies, we will pursue commercialization in the medical and welfare sectors, where growth in the regenerative medicine-related industry and demand for labor-saving solutions in welfare are expected, and in the agricultural sector, where expectations are rising for food safety and a stable food supply.」
The policy of pursuing commercialization in the medical, welfare and agricultural sectors by utilizing existing technologies is reiterated. - FY2017-Q1First statedAnnual report
「We will pursue commercialization in the medical and welfare sectors, where demand is expected to grow for regenerative medicine and labor-saving solutions in welfare, and in the agricultural sector, where expectations are rising for food safety and a stable food supply.」
The company has identified entry into new fields using its Motion & Energy Control and measurement and control technologies.